NCT01180764

Effects of Lovaza on High Density Lipoprotein (HDL) Composition and Function in Hypertriglyceridemia

Effects of Lovaza Monotherapy vs. Placebo on Composition and Function of HDL and Other Lipoproteins, and on Other Lipid-Related Parameters

• Status: Withdrawn
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: University of Utah · Academic / Other
• Sex: All
• Age: 35 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

Study hypothesis: Lovaza (purified prescription fish oil) is likely to help HDL (the "good cholesterol") work better. Study summary: We are testing effects of Lovaza versus placebo, on various aspects of HDL and other lipoproteins, in patients with high triglyceride levels. Study funding: This study is being funded by an investigator-initiated research grant from Glaxo Smith Kline.

Conditions

• Hypertriglyceridemia

Interventions

Type	Name	Description
DRUG	Lovaza (Omega-3 acid ethyl esters)	1g capsules, 4 capsules po daily
DRUG	Placebo	Placebo matching active lovaza, 1 g capsules, 4 capsules po daily

Timeline

• Start date: 2010-08-01
• Primary completion: 2012-08-01
• Completion: 2012-10-01
• First posted: 2010-08-12
• Last updated: 2016-02-08

Locations

1 site across 1 country: United States